Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 2
2009 2
2010 5
2011 3
2012 7
2013 7
2014 9
2015 17
2016 14
2017 8
2018 9
2019 6
2020 9
2021 11
2022 11
2023 7
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean xiao mao guo (42 results)?
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial.
Chen L, Jiang YZ, Wu SY, Wu J, Di GH, Liu GY, Yu KD, Fan L, Li JJ, Hou YF, Hu Z, Chen CM, Huang XY, Cao AY, Hu X, Zhao S, Ma XY, Xu Y, Sun XJ, Chai WJ, Guo X, Chen X, Xu Y, Zhu XY, Zou JJ, Yang WT, Wang ZH, Shao ZM. Chen L, et al. Among authors: guo x. Clin Cancer Res. 2022 Jul 1;28(13):2807-2817. doi: 10.1158/1078-0432.CCR-21-4313. Clin Cancer Res. 2022. PMID: 35247906 Free PMC article.
Targeting deubiquitinase USP28 for cancer therapy.
Wang X, Liu Z, Zhang L, Yang Z, Chen X, Luo J, Zhou Z, Mei X, Yu X, Shao Z, Feng Y, Fu S, Zhang Z, Wei D, Jia L, Ma J, Guo X. Wang X, et al. Among authors: guo x. Cell Death Dis. 2018 Feb 7;9(2):186. doi: 10.1038/s41419-017-0208-z. Cell Death Dis. 2018. PMID: 29415985 Free PMC article. Review.
The function of EMSY in cancer development.
Hou J, Wang Z, Yang L, Guo X, Yang G. Hou J, et al. Among authors: guo x. Tumour Biol. 2014 Jun;35(6):5061-6. doi: 10.1007/s13277-013-1584-3. Epub 2014 Mar 9. Tumour Biol. 2014. PMID: 24609898 Review.
CDK4/6 inhibitors: a novel strategy for tumor radiosensitization.
Yang Y, Luo J, Chen X, Yang Z, Mei X, Ma J, Zhang Z, Guo X, Yu X. Yang Y, et al. Among authors: guo x. J Exp Clin Cancer Res. 2020 Sep 15;39(1):188. doi: 10.1186/s13046-020-01693-w. J Exp Clin Cancer Res. 2020. PMID: 32933570 Free PMC article. Review.
A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer.
Wang B, Sun T, Zhao Y, Wang S, Zhang J, Wang Z, Teng YE, Cai L, Yan M, Wang X, Jiang Z, Pan Y, Luo J, Shao Z, Wu J, Guo X, Hu X. Wang B, et al. Among authors: guo x. Nat Commun. 2022 Jul 12;13(1):4025. doi: 10.1038/s41467-022-31704-7. Nat Commun. 2022. PMID: 35821019 Free PMC article. Clinical Trial.
122 results